Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing bosentan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan 62.5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bosentan 125mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bosentan monohydrate (substance) |
Is a |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan 125 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only bosentan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan monohydrate (substance) |
Is modification of (attribute) |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bosentan hydrochloride |
Is modification of (attribute) |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely bosentan (as bosentan hydrochloride) 62.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely bosentan (as bosentan hydrochloride) 125 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan 62.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan 62.5 mg oral tablet |
Has precise active ingredient |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Bosentan anhydrous (substance) |
Is modification of (attribute) |
True |
Bosentan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|